Skip to main content

Children, Only

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Kalbe
KalbeIndonesia - Jakarta
1 program
1
Formula milk with triple Bifidobacterium probiotic strainPhase 11 trial
Active Trials
NCT06044376Unknown103Est. Mar 2024
Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
Changes in pesticide exposureN/A1 trial
Active Trials
NCT03319927Completed987Est. Aug 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
KalbeFormula milk with triple Bifidobacterium probiotic strain
Oregon TherapeuticsChanges in pesticide exposure

Clinical Trials (2)

Total enrollment: 1,090 patients across 2 trials

NCT06044376KalbeFormula milk with triple Bifidobacterium probiotic strain

Ingestion Effect of Formula Milk With Triple Bifidobacteria Strains on Fecal Quality and Metabolites in Healthy Children

Start: May 2023Est. completion: Mar 2024103 patients
Phase 1Unknown
NCT03319927Oregon TherapeuticsChanges in pesticide exposure

Reducing Pesticide Exposures in Child Care Centers

Start: Oct 2017Est. completion: Aug 2024987 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.